| Finding | Percentage | Cases |
|---|---|---|
| Gender | ||
| Male | 65.2% | 15/23 |
| Female | 34.8% | 8/23 |
| Indifferent | 0% | 0/23 |
| Unknown | 0% | 0/23 |
| General | ||
| Birth Length | 0% | 0/23 |
| Birth Weight | 0% | 0/23 |
| Birth Head circumference | 0% | 0/23 |
| Current Height | 0% | 0/23 |
| Current Weight | 0% | 0/23 |
| Current Head circumference | 0% | 0/23 |
| 87% | 20/23 | |
| 95.5% | 21/22 | |
| 100% | 23/23 | |
| 68.2% | 15/22 | |
| Neurology | ||
| 100% | 23/23 | |
| 13% | 3/23 | |
| 69.6% | 16/23 | |
| Facial abnormalities | ||
| 4.3% | 1/23 | |
| 26.1% | 6/23 | |
| 21.7% | 5/23 | |
| 43.5% | 10/23 | |
| Visual and hearing impairments | ||
| 8.7% | 2/23 | |
| 8.7% | 2/23 | |
| Heart | ||
| 4.3% | 1/23 | |
| Gastrointestinal | ||
| 4.3% | 1/23 | |
| Urogenital | ||
| 8.7% | 2/23 | |
| Skeleton | ||
| 60.9% | 14/23 | |
| Skin / Hair / Nails | ||
| 13% | 3/23 | |
| Endocrine / Immunological / Metabolic | ||
| 4.3% | 1/23 | |
| 21.7% | 5/23 | |
| Immune | 0% | 0/23 |
| Neoplasia | ||
| Neoplasia | 0% | 0/23 |
| Inheritance | ||
| 100% | 23/23 | |
TBCK